{"log_id": 5460148181745662509, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 1.7e-05, "average": 0.997429, "min": 0.982728}, "location": {"width": 939, "top": 128, "height": 59, "left": 125}, "words": "反应率相似。然而,<50个/mm3的患者中有1%完全缓解,而CD4水平最高的患者中有10%完全缓"}, {"probability": {"variance": 0, "average": 0.998882, "min": 0.998882}, "location": {"width": 25, "top": 209, "height": 25, "left": 127}, "words": "解"}, {"probability": {"variance": 0.001309, "average": 0.988302, "min": 0.784722}, "location": {"width": 889, "top": 229, "height": 53, "left": 176}, "words": "为了充分证明盐酸多柔比星脂质体的有效性,进行了盐酸多柔比星脂质体(20mg/m2)与ABV[多"}, {"probability": {"variance": 0.001916, "average": 0.988356, "min": 0.689516}, "location": {"width": 933, "top": 278, "height": 57, "left": 126}, "words": "柔比星(20mgm2)、博莱霉素(10U/m2)及长春新碱(1mgm2)]的前瞻性随机平行对照多中心研究"}, {"probability": {"variance": 0.001185, "average": 0.992234, "min": 0.767005}, "location": {"width": 941, "top": 326, "height": 57, "left": 130}, "words": "盐酸多柔比星脂质体组和ABV组每2周给药一次,最多6次。该研究包括258名中至重度卡波氏肉"}, {"probability": {"variance": 3.3e-05, "average": 0.99649, "min": 0.971429}, "location": {"width": 942, "top": 375, "height": 59, "left": 130}, "words": "瘤患者(患者统计:男性98%,高加索人75%,平均年龄38岁,同性恋>90%),用盐酸多柔比星脂"}, {"probability": {"variance": 6.9e-05, "average": 0.996502, "min": 0.964176}, "location": {"width": 917, "top": 426, "height": 57, "left": 133}, "words": "质体和ABV治疗的患者数分别为133和125例,和前述研究一样,大部分患者成为预后不佳人群"}, {"probability": {"variance": 6e-06, "average": 0.998488, "min": 0.988684}, "location": {"width": 881, "top": 476, "height": 55, "left": 184}, "words": "主要的疗效终点指标基于治疗的反应率(5个标准:完全缓解,临床完全缓解,部分缓解,稳定"}, {"probability": {"variance": 0.000792, "average": 0.991281, "min": 0.811303}, "location": {"width": 941, "top": 526, "height": 56, "left": 133}, "words": "疾病进展),而临床受益是建立在患者的癌性疼痛、与肿瘤相关的全身症状和体征、体力状况评分(KPS)"}, {"probability": {"variance": 0.00206, "average": 0.98772, "min": 0.726842}, "location": {"width": 940, "top": 575, "height": 57, "left": 137}, "words": "和两种生活质量评分(QOL)基础上的评价。一项评价QOL的问卷专门针对与艾滋病相关的卡波氏肉"}, {"probability": {"variance": 5.1e-05, "average": 0.995393, "min": 0.970931}, "location": {"width": 512, "top": 637, "height": 45, "left": 135}, "words": "瘤,其它的评价采用了“药物疗效研究”( Medical Out"}, {"probability": {"variance": 0.000227, "average": 0.993408, "min": 0.938131}, "location": {"width": 371, "top": 625, "height": 40, "left": 707}, "words": "Sudy)获得的方法,该方法使用了“药"}, {"probability": {"variance": 0.001456, "average": 0.987852, "min": 0.777215}, "location": {"width": 940, "top": 674, "height": 57, "left": 138}, "words": "物疗效研究“中的与HIV相关的项目,并通过比较无症状HIV感染者和带有艾滋病相关综合征患者"}, {"probability": {"variance": 8e-06, "average": 0.998114, "min": 0.992592}, "location": {"width": 112, "top": 751, "height": 27, "left": 139}, "words": "而得到验证"}, {"probability": {"variance": 1.4e-05, "average": 0.998573, "min": 0.977803}, "location": {"width": 889, "top": 773, "height": 55, "left": 192}, "words": "治疗终点的完全部分反应率证明了一个有利于盐酸多柔比星脂质体组的显著的统计学差异,盐"}, {"probability": {"variance": 0.000457, "average": 0.993366, "min": 0.892765}, "location": {"width": 941, "top": 822, "height": 57, "left": 141}, "words": "酸多柔比星脂质体组和ABV组的反应率分别为46%和26%。两组缓解持续时间相似(盐酸多柔比星"}, {"probability": {"variance": 0.000866, "average": 0.991327, "min": 0.818889}, "location": {"width": 941, "top": 872, "height": 55, "left": 143}, "words": "脂质体组与ABV组平均缓解持续时间分别为92.5天与84.8天,中位缓解持续时间分别为90天与92"}, {"probability": {"variance": 9.6e-05, "average": 0.996165, "min": 0.943178}, "location": {"width": 935, "top": 918, "height": 61, "left": 143}, "words": "天)。除瘤体大小以外的其他病灶特征(如厚度、结节、水肿、颜色和疼痛)的结果表明与基值相比"}, {"probability": {"variance": 0.001032, "average": 0.989931, "min": 0.824571}, "location": {"width": 945, "top": 969, "height": 58, "left": 143}, "words": "两组均有所改善。死亡不是其中的一项研究终点,但盐酸多柔比星脂质体的中位生存期为160天,ABV"}, {"probability": {"variance": 1.3e-05, "average": 0.995438, "min": 0.991745}, "location": {"width": 89, "top": 1046, "height": 27, "left": 148}, "words": "为153天"}, {"probability": {"variance": 0.001068, "average": 0.99174, "min": 0.787441}, "location": {"width": 893, "top": 1068, "height": 55, "left": 195}, "words": "关于QOL答卷,在九个方面中有五个利于盐酸多柔比星脂质体组的统计学的显著差异:总健康"}, {"probability": {"variance": 0.006414, "average": 0.985608, "min": 0.461271}, "location": {"width": 942, "top": 1116, "height": 59, "left": 148}, "words": "水平、疼痛、社交功能、体力水平和健康隐患。有关针对与卡波氏肉瘤相关的问卷,在无个方面中有"}, {"probability": {"variance": 0.001338, "average": 0.992256, "min": 0.755782}, "location": {"width": 944, "top": 1166, "height": 58, "left": 148}, "words": "四个有利于盐酸多柔比星脂质体组的显著统计学差异:肺功能障碍/疼痛,头部肢体活动受限,运动"}, {"probability": {"variance": 2e-06, "average": 0.999034, "min": 0.995495}, "location": {"width": 178, "top": 1240, "height": 32, "left": 150}, "words": "受限以及睡眠障碍"}, {"probability": {"variance": 0.007174, "average": 0.980506, "min": 0.455417}, "location": {"width": 900, "top": 1265, "height": 57, "left": 198}, "words": "综上所述,这一研究表明盐酸多柔比星脂质体与ABV方案有相同效果在某些方面优彩ABV"}, {"probability": {"variance": 0.005118, "average": 0.982037, "min": 0.523531}, "location": {"width": 941, "top": 1316, "height": 57, "left": 152}, "words": "组,如,疾病症状和容颜改善方面。尽管ABV组中没有一个药物是批准用治疗AIDS-KS,但这种"}, {"probability": {"variance": 0.009528, "average": 0.97912, "min": 0.436489}, "location": {"width": 853, "top": 1364, "height": 62, "left": 152}, "words": "选择是较合理的,因为,它是目前公认的治疗晚期 aids-ks的有效组合方案C"}, {"probability": {"variance": 0.001513, "average": 0.986592, "min": 0.783782}, "location": {"width": 893, "top": 1416, "height": 54, "left": 204}, "words": "阳性对照研究(30-11)设计为盐酸多柔比星脂质体组与BV组(博莱霉素与长春新碱)的随机"}, {"probability": {"variance": 4e-06, "average": 0.998969, "min": 0.990775}, "location": {"width": 943, "top": 1465, "height": 56, "left": 156}, "words": "比较试验。通过与已有治疗方法的比较判断盐酸多柔比星脂质体对受试者的有效性,评价患有中至重"}, {"probability": {"variance": 2e-06, "average": 0.999006, "min": 0.994052}, "location": {"width": 393, "top": 1530, "height": 40, "left": 157}, "words": "度卡波氏肉瘤患者的用药安全性和耐受性"}, {"probability": {"variance": 0.000107, "average": 0.996362, "min": 0.932931}, "location": {"width": 895, "top": 1564, "height": 54, "left": 206}, "words": "共有241例中至重度卡波氏肉瘤患者参加,其中218例可用于疗效的评价。盐酸多柔比星脂质"}], "language": 3}